Zepon Beta 20 Tablet contains a combination of Clonazepam (0.25 mg) and Propranolol (20 mg), formulated to provide therapeutic benefits in the management of anxiety disorders, panic attacks, and certain cardiovascular conditions. Clonazepam, a benzodiazepine, exerts its effect by enhancing the activity of gamma-aminobutyric acid (GABA), a neurotransmitter that inhibits excessive neuronal activity, thereby producing anxiolytic, anticonvulsant, and muscle-relaxant properties. Propranolol, a non-selective beta-adrenergic blocker, acts by blocking beta-1 and beta-2 adrenergic receptors, leading to decreased heart rate, myocardial contractility, and blood pressure, which is beneficial in controlling symptoms of hypertension, angina, and arrhythmias. The combination in Zepon Beta 20 is particularly useful in patients experiencing anxiety with concomitant cardiovascular symptoms such as tachycardia or hypertension. It should be administered under medical supervision with careful consideration of contraindications including respiratory disorders, bradycardia, and hypersensitivity to either component. Dosage should be individualized based on clinical response and tolerability. Patients should be monitored for potential side effects such as drowsiness, dizziness, hypotension, and bradycardia. Abrupt discontinuation should be avoided to prevent withdrawal symptoms. Zepon Beta 20 Tablet is intended for use as prescribed by a healthcare professional.